McKesson Corporation (NYSE:MCK) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.
- Updated: September 29, 2016
Zacks Investment Research has downgraded McKesson Corporation (NYSE:MCK) to Sell in a statement released on 9/29/2016.
On 09/26/2016, Mizuho Securities released a statement on McKesson Corporation (NYSE:MCK) dropped the target price from $197.00 to $183.00 that suggested an upside of 0.10%.
Having a price of $165.40, McKesson Corporation (NYSE:MCK) traded -0.44% lower on the day. With the last close down -7.28% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. McKesson Corporation has recorded a 50-day average of $181.13 and a two hundred day average of $178.92. Volume of trade was down over the average, with 343,961 shares of MCK changing hands under the typical 1,503,880
With a total market value of $0, McKesson Corporation has price-earnings ratio of 17.23 with a one year low of $148.29 and a one year high of $202.20 .
A total of 15 analysts have released a report on McKesson Corporation. Four analysts rating the company a strong buy, seven analysts rating the company a buy, seven analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $195.93.
More About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.